This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights Apple, Taiwan Semiconductor, NVIDIA, Salesforce, and Amazon.com
by Zacks Equity Research
Apple, Taiwan Semiconductor, NVIDIA, Salesforce, and Amazon.com are included in this Analyst Blog.
Salesforce.com (CRM) Is Up 3.29% in One Week: What You Should Know
by Zacks Equity Research
Does Salesforce.com (CRM) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Zacks Analyst Blog Highlights Alphabet, Salesforce, Comcast, Colgate-Palmolive and American Water Works
by Zacks Equity Research
Alphabet, Salesforce, Comcast, Colgate-Palmolive and American Water Works are part of the Zacks top Analyst Blog.
3 Blue-Chip Stocks to Buy as the Dow Breezes Past 38,000
by Tirthankar Chakraborty
As the Dow continues to scale upward, it's prudent to invest in stocks such as Microsoft (MSFT), Salesforce (CRM) and Apple (AAPL) that are listed on the said index and are financially sound.
The Zacks Analyst Blog Highlights Apple, Taiwan Semiconductor, NVIDIA, Salesforce and Amazon.com
by Zacks Equity Research
Apple, Taiwan Semiconductor, NVIDIA, Salesforce and Amazon.com are part of the Zacks top Analyst Blog.
Top Stock Reports for Alphabet, Salesforce & Comcast
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Salesforce, Inc. (CRM) and Comcast Corporation (CMCSA).
Here's Why Investors Should Add Salesforce (CRM) to Portfolio
by Zacks Equity Research
Salesforce (CRM) appears to be an enticing investment option at the moment, with healthy fundamentals and upward estimate revisions.
Wall Street Bulls Look Optimistic About Salesforce.com (CRM): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Salesforce.com (CRM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
If You Invested $1000 in Salesforce.com a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
3 S&P 500 Growth Stocks to Buy as Index Enjoys Bull Market
by Tirthankar Chakraborty
With the S&P 500 confirming the bull market, it's wise for investors to invest in growth stocks such as NVIDIA (NVDA), Salesforce (CRM), and Amazon.com (AMZN).
Should Invesco Large Cap Growth ETF (PWB) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PWB
Should You Invest in the iShares Expanded Tech-Software Sector ETF (IGV)?
by Zacks Equity Research
Sector ETF report for IGV
Salesforce.com (CRM) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Salesforce.com (CRM) closed at $274.46 in the latest trading session, marking a +1.11% move from the prior day.
BOX Bolsters Box Sign Portfolio With FDA Part 11 Approval
by Zacks Equity Research
BOX receives FDA 21 CFR Part 11 approval for electronic signatures, facilitating research, development and manufacturing processes without incurring incremental costs.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Salesforce (CRM) Unveils GenAI-Powered Tools for Retailers
by Zacks Equity Research
Salesforce (CRM) brings generative AI to its Commerce Cloud and Marketing Cloud solutions, which is likely to help retail merchandisers optimize their business operations while enhancing shoppers' experience.
Salesforce.com (CRM) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
The latest trading day saw Salesforce.com (CRM) settling at $271.93, representing a +0.2% change from its previous close.
Adobe (ADBE) Up 2.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Adobe (ADBE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Infosys (INFY) Gains 4% as Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Infosys' (INFY) better-than-expected Q3 performance reflects the benefits of strong sales executions and improved operational efficiencies.
Amazon (AMZN) Teams Up With Salesforce to Boost Prime Momentum
by Zacks Equity Research
Amazon (AMZN) partners with Salesforce to integrate Buy with Prime into the latter's Commerce Cloud platform.
Bridgeline (BLIN) Strengthens Portfolio With HawkSearch Launch
by Zacks Equity Research
Bridgeline's (BLIN) HawkSearch AI unveils Smart Search, transforming e-commerce with advanced AI for precise, image-enhanced searches.
The Zacks Analyst Blog Highlights Merck, Salesforce, Philip Morris International, Novartis and CME Group
by Zacks Equity Research
Merck, Salesforce, Philip Morris International, Novartis and CME Group are part of the Zacks top Analyst Blog.
Top Analyst Reports for Merck, Salesforce & Philip Morris
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM) and Philip Morris International Inc. (PM).
Wall Street Analysts Think Salesforce.com (CRM) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.